Stockreport

Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bi [Read more]